deltatrials
Unknown OBSERVATIONAL NCT01023971

Macular Function During Anti-VEGF Treatment (MAFAT)

Study of Macular Function During Anti-VEGF Treatment

Sponsor: Royal Liverpool University Hospital

Updated 5 times since 2017 Last updated: Dec 1, 2009 Started: Jan 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01023971, this observational or N/A phase trial focuses on Age Related Macular Degeneration and remains ongoing. Sponsored by Royal Liverpool University Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotUnknown Status~Apr 2018 – ~Jan 2021 · 33 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Apr 2018 — Jan 2021 [monthly]

    Unknown Status

    Phase: NANone

  5. Jan 2017 — Apr 2018 [monthly]

    Unknown Status NA

    First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Royal Liverpool University Hospital
Data source: Royal Liverpool University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations